Fidelity Investments
HELP

Fidelity Investments’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Fidelity Investments’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24
Closed -$489 – 5472
2023
Q3 		$489 Buy
+24
New +$353 ﹤0.01% 4716

Other funds holding HELP

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
LAM
Lewis Asset Management Lafayette, California $285M AUM 32.52% 1-Year Est. Return

Fidelity Investments's HELP Position: Q4 2023 in Review

Fidelity Investments sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2023, closing a stake of 24 shares — an estimated $489 sold.

Fidelity Investments first reported a position in HELP in Q3 2023 and held it in 1 quarter. The position peaked at $489 in Q3 2023. 86 funds tracked by Wall St. Rank hold HELP as of Q4 2023.

  • Fidelity Investments reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 24 Helus Pharma Inc. Common Stock shares in Q4 2023, an estimated $489.
  • Fidelity Investments first reported a position in Helus Pharma Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Fidelity Investments's Helus Pharma Inc. Common Stock position peaked at $489 in Q3 2023.
  • 86 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.